MedTrace Logo

Hmong Microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C)

NCT04938024 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2023-09-07

No results posted yet for this study

Summary

Investigators seek to quantify the impact of vitamin C on patient outcomes, including serum urate level, gout-related symptoms, and obesity (measured by BMI) in both healthy Hmong adults and in Hmong patients with hyperuricemia (HU) and/or gout; identify associations between individuals' taxonomic and functional patterns of gut microbiota and its impact on the serum urate-lowering effect of vitamin C; compare taxonomic and functional patterns of gut microbiota between people with HU and/or gout and people without HU and gout; and identify associations between individuals' taxonomic and functional patterns of gut microbiota and self-reported acute gout trigger foods.

Conditions

  • Hyperuricemia
  • Gout

Interventions

DIETARY_SUPPLEMENT

Vitamin C

Vitamin C is a commercially available over-the-counter food supplement.

Sponsors & Collaborators

Principal Investigators

  • Robert J Straka, PharmD, FCCP · Univeristy of Minnesota Department of Experimental and Clinical Pharmacology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-28
Primary Completion
2023-08-30
Completion
2023-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04938024 on ClinicalTrials.gov